AwardedSWEGoodsSEK 35,000,000
Denosumab och Glyceryltrinitrat
- Published
- Published 30 March 2026
- Deadline
- Closed 28 April 2026
Overview
Region Västernorrland procured pharmaceutical supplies for Denosumab and Glyceryltrinitrat on behalf of the Northern Healthcare Region and four regional health authorities through a requisition procedure. The contract was awarded on 19 May 2026 to six suppliers: BIOCON BIOLOGICS IRELAND LIMITED, Celltrion Sweden AB, Fresenius Kabi AB, Macure Pharma ApS, Samsung Bioepis NL B.V., and Zentiva Denmark Aps, with a total awarded value of 4,166,666.67 SEK.
Key details
- Country
- SWE
- Status
- Awarded
- Category
- Goods
- Estimated value
- SEK 35,000,000
- Procedure
- Open
- Published
- 30 March 2026
- Deadline
- Closed
Pharmaceutical products
Award outcome
- Awarded value
- SEK 4,166,667
- Award date
- 19 May 2026
- Contract period
- 1 September 2026 → 31 August 2030
- BIOCON BIOLOGICS IRELAND LIMITED
- Celltrion Sweden AB
- Fresenius Kabi AB
- Macure Pharma ApS
- Samsung Bioepis NL B.V.
- Zentiva Denmark Aps
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
26 June 2026
Contract Notice
30 March 2026
Contracting authority
Region Västernorrland
Procuring entityHärnösand, SWE
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.